1

加藤晃，山本恵子．

研究論文紹介：ヘリックス12 を安定化するビタミンD 受容体アンタゴニスト．ビタミン．2017. 91, 129–131

 

2

山本恵子．

スタンダード薬学シリーズ II　第３巻 化学系薬学Ⅱ 生体分子?医薬品の化学による理解; SBO17, 18, 33, 34. 日本薬学会編，東京化学同人．2016，pp143-157, 260-271．

 

3

Yamamoto K, Anami Y, Itoh T.

Development of vitamin D analogues that modulate the pocket structure of vitamin D receptor.

Curr. Top. Med. Chem. 2014, 14, 2378-2387. DOI: 10.2174/156802661421141223091909. [PubMed]

 

4

Inui H, Itoh T, Yamamoto K, Ikushiro S, Sakaki T.

Mammalian cytochrome P450-dependent metabolism of polychlorinated dibenzo-p-dioxins and coplanar polychlorinated biphenyls.

Int. J. Mol. Sci. 2014, 15, 14044-14057. doi:10.3390/ijms150814044. [IJMS]

 

5

Sakaki T, Yasuda K, Kittaka A, Yamamoto K, Chen TC.

CYP24A1 as a potential target for cancer therapy.

Anticancer Agents Med. Chem. 2014, 14, 97-108.

 

6

山本恵子．

ビタミンＤと関連タンパク質（CYP，DBP，VDR）の構造生命科学．ビタミン．2013, 87, 669-677.

 

7

Sakaki T, Yamamoto K, Ikushiro S.

Possibility of application of cytochrome P450 to bioremediation of dioxins.

Biotechnol. Appl. Bioc. 2013, 60, 65-70.

 

8

Chen TC, Sakaki T, Yamamoto K, Kittaka A.

The Roles of Cytochrome P-450 Enzymes in Prostate Cancer Development and Treatment.

Anticancer Res. 2012, 32, 291-298.

 

9

山本恵子．

酵素-基質ドッキングモデル．ビタミン総合事典．日本ビタミン学会．朝倉書店，2010, pp78-81.

 

10

Keiko Yamamoto.

Active vitamin D: From the vitamin to the hormone.

International Medical News. 2008, No 432, 6-7.

 

11

Itoh T, Yamamoto K.

Peroxisome Proliferator Activated Receptorg and Oxidized Docosahexaenoic Acids as New Class of Ligand.

Naunyn Schmiedebergs Arch. Pharmacol. 2008, 377, 541–547.